China Medical Tech. (CMED) Reports Strong Q4 Results
China Medical Technologies, Inc. (Nasdaq: CMED) reports Q4 EPS of $0.60, versus the analyst estimate of $0.43. Revenue for the quarter was $36 million, versus the consensus of $35.28 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
